Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed

HORSHAM, England, March 10, 2020 /PRNewswire/ — Cmed Clinical Research Services will present a webinar to discuss key challenges in data collection for Real-World Studies on March 30. The session will focus on strategies and system features to help facilitate data acquisition, as well as ways to manage data effectively to ensure high-quality and efficient data flow.

Cmed staff Kirsten Bulpitt, Director of Clinical Data Management, and Stephane Forrer, Associate Director of Systems Management, will present the live webinar on Monday, March 30, 2020, at 10 a.m. EDT (3 p.m. BST/UK).

There is an increasing drive and focus on the collection and use of real-world data within the pharmaceutical industry. With advances in technology and further development of personalized medicine, the demand for real-world data to support the drug development lifecycle continues to gain momentum, as well as support, from regulatory agencies.

The field of real-world data extends across a diverse spectrum of data sources from the unstructured (e.g. EHRs and wearables) to the more structured observational and registry studies. This webinar will focus on the data collection and system challenges in structured observational and registry studies collecting retrospective and prospective real-world data.

This webinar will:

  • Present key challenges in data collection
  • Review strategies and system features to help facilitate data acquisition
  • Demonstrate effective management of data to ensure high-quality and efficient data flow
  • Discuss the maintenance of efficient data flows
  • Draw examples from experience in oncology research

For more information or to register for this event, visit Overcoming Data Collection and System Challenges in Real-World Studies.

About Cmed Clinical Research Services

Cmed provides specialist data and analytics services for clinical trials with over 350 staff globally. The company has delivered over 700 studies across all phases with clients from top 10 pharma companies to small biopharma.

Cmed has experience in managing large registry studies, understands their unique challenges and uses technologies, including encapsia, to optimize complex data flows to allow greater flexibility and provide real-time visual access to all study data.

Cmed Clinical Research Services

Ashurst, Broadlands Business Campus

Langhurstwood Road, Horsham RH12 4QP, UK

+44 1403 755 050

Contacts: 

Ian Macholl, Marketing Manager, Cmed Group.

T: +44 1403 755 050 E: imacholl@cmedgroup.com

Stephanie Langouet, Chief Operations Officer, Cmed Clinical Research Services.

T: +44 1403 755 050 E: slangouet@cmedresearch.com

Related Images

image1.png

View original content to download multimedia:http://www.prnewswire.com/news-releases/overcoming-data-collection-and-system-challenges-in-real-world-studies-upcoming-webinar-presented-byr-cmed-301020850.html

SOURCE Cmed Clinical Research Services

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

17 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

17 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

17 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

17 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

17 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

17 hours ago